Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 68 peer-reviewed journal articles Updated

Cerebrotendinous Xanthomatosis (CTX) Resource Guide

At a Glance

Cerebrotendinous Xanthomatosis (CTX) is a rare but highly treatable metabolic disorder. By taking standard medication to replace a missing bile acid, patients can stop the toxic buildup that causes symptoms and protect their long-term health.

Welcome to your comprehensive guide on Cerebrotendinous Xanthomatosis (CTX). Receiving this diagnosis can feel overwhelming, but you are not alone. This resource is designed to help you understand your diagnosis, recognize your symptoms, navigate your lab reports, and build an expert care team.

CTX is a rare, highly treatable metabolic disorder. By replacing a missing bile acid with a standard medication, you can stop the toxic buildup that causes symptoms and protect your long-term health.

Please explore the detailed pages below to empower yourself for the journey ahead:

01

Understanding Your Diagnosis: An Introduction to CTX

Learn what a cerebrotendinous xanthomatosis (CTX) diagnosis means. Understand the genetic causes, common symptoms, and how CDCA treatment stops progression.

02

Recognizing the Signs: CTX Symptoms Across the Lifespan

Learn about the symptoms of Cerebrotendinous xanthomatosis (CTX) at every stage of life. Understand early red flags like juvenile cataracts to adult signs.

03

The Biology of CTX and Why It Is Often Misdiagnosed

Understand the biology of Cerebrotendinous Xanthomatosis (CTX) and why its symptoms are frequently misdiagnosed as Multiple Sclerosis, ADHD, or dementia.

04

Diagnosis & Lab Reports: Understanding Your Tests

Learn how Cerebrotendinous Xanthomatosis (CTX) is diagnosed. Understand key lab reports including serum cholestanol, urine bile alcohols, and CYP27A1 testing.

05

Treatment Strategy: The Path to Stability

Learn the treatment strategy for Cerebrotendinous Xanthomatosis (CTX). Understand how CDCA therapy works to lower cholestanol and stop disease progression.

06

Building Your Care Team & Long-Term Monitoring

Learn how to build a care team and monitor Cerebrotendinous Xanthomatosis (CTX). Understand CDCA therapy tracking, cholestanol tests, and brain MRI scans.

Common questions in this guide

What is Cerebrotendinous Xanthomatosis (CTX)?
CTX is a rare metabolic disorder caused by the body's inability to produce a specific bile acid. This missing bile acid leads to a toxic buildup of substances in the body that can cause various symptoms.
Is CTX a treatable condition?
Yes, CTX is highly treatable. By replacing the missing bile acid with a standard daily medication, you can stop the toxic buildup in your body and protect your long-term health.
What should I ask my doctor after being diagnosed with CTX?
It is helpful to ask your doctor to review your treatment timeline so you can set realistic expectations for your progress. You should also ask how often your care plan and symptoms will be monitored and adjusted.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my specific diagnosis, which section of this guide should we focus on first?
  2. 2.Can we review my treatment timeline to set realistic expectations for my progress?
  3. 3.How often should we revisit my care plan as my symptoms or treatments evolve?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

This guide is for informational purposes only and does not replace professional medical advice. Always consult your healthcare provider or metabolic specialist regarding your CTX diagnosis and treatment plan.

Get notified when new evidence is published on Cerebrotendinous xanthomatosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.